TD
Tejas Deepak Naphade
About Tejas Deepak Naphade
Data last updated:
Tejas Deepak Naphade is a Director at Quality Care India Limited (since 2023) and Nominee Director at International Gemological Institute Limited (since 2023). The companies operate in Healthcare, Education and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹2,124 Cr; the largest is Quality Care India Limited at ₹1,624 Cr (FY 2023). Earlier, Tejas Deepak Naphade was a Director at United Ciigma Institute Of Medical Sciences Private Limited (2023–2025) and Nominee Director at Condis India Healthcare Private Limited (2024) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Oct 2023 | 1992 | ₹1,624 Cr (FY 2023) | Active | |
| Nominee Director | 26 Jul 2023 | 1999 | ₹500 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Nov 2023 | 2011 | ₹147 Cr (FY 2025) | Active | |
| Nominee Director | 23 Jan 2024 | 2006 | ₹1,286 Cr (FY 2025) | Amalgamated | |
| Nominee Director | 23 Jan 2024 | 1995 | ₹1,282 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Tejas Deepak Naphade
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejas Deepak Naphade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejas Deepak Naphade
Tejas Deepak Naphade currently holds 2 directorships: Quality Care India Limited (Director, since 27 Oct 2023, revenue ₹1,624 Cr (FY 2023)); International Gemological Institute Limited (Nominee Director, since 26 Jul 2023, revenue ₹500 Cr (FY 2023)).
Tejas Deepak Naphade was first appointed on 26 Jul 2023 as Nominee Director at International Gemological Institute Limited. The most recent appointment on record is 23 Jan 2024 at Kims Health Care Management Limited.
The 2 current companies of Tejas Deepak Naphade that report revenue have a combined latest revenue of ₹2,124 Cr: Quality Care India Limited ₹1,624 Cr (FY 2023); International Gemological Institute Limited ₹500 Cr (FY 2023).
Tejas Deepak Naphade held 3 earlier board appointments: United Ciigma Institute Of Medical Sciences Private Limited (Director, 17 Nov 2023 to 20 Nov 2025); Condis India Healthcare Private Limited (Nominee Director, 23 Jan 2024 to 26 Jun 2024); Kims Health Care Management Limited (Nominee Director, 23 Jan 2024 to 26 Jun 2024).
The current boards of Tejas Deepak Naphade's companies include Aniket Damle (Quality Care India Limited), Ayshwarya Ravi Vikram (Quality Care India Limited), Ekta Bahl (Quality Care India Limited), Ganesh Mani (Quality Care India Limited), Gayathri Sathanoor Chandramoulieswaran (Quality Care India Limited), Himanshu Dodeja (Quality Care India Limited), among others.